Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 3436 AL 3450

Pathobiological Subtypes of Alzheimer Disease

Jellinger KA.

Dement Geriatr Cogn Disord. 2020;49(4):321-333. doi: 10.1159/000508625. Epub 2021 Jan 11.

A Comparison of Neurocognitive Decline in Older Adults in Same-Sex and Opposite-Sex Relationships

Manca R, Venneri A.

Curr Alzheimer Res. 2020;17(12):1102-1114. doi: 10.2174/1567205018666210114111556.

Regulatory microRNAs and vascular cognitive impairment and dementia

Zhang J, Sun P, Zhou C, Zhang X, Ma F, Xu Y, Hamblin MH, Yin KJ.

CNS Neurosci Ther. 2020 Dec;26(12):1207-1218. doi: 10.1111/cns.13472.

Dementia is Associated with Severe Coronavirus Disease 2019 (COVID-19) Infection

Hariyanto TI, Putri C, Situmeang RFV, Kurniawan A.

Am J Med Sci. 2021 Mar;361(3):394-395. doi: 10.1016/j.amjms.2020.10.026. Epub 2020 Oct 28.

A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment

Garibotto V, Trombella S, Antelmi L, Bosco P, Redolfi A, Tabouret-Viaud C, Rager O, Gold G, Giannakopoulos P, Morbelli S, Nobili F, Perneczky R, Didic M, Guedj E, Drzezga A, Ossenkoppele R, Berckel BV, Ratib O, Frisoni GB.

Curr Alzheimer Res. 2020;17(13):1186-1194. doi: 10.2174/1567205018666210212162443.

Postoperative Cognitive Dysfunction and the Protective Effects of Enriched Environment: A Systematic Review

Hua M, Min J.

Neurodegener Dis. 2020;20(4):113-122. doi: 10.1159/000513196. Epub 2021 Feb 18.

Immunological and hormonal mechanisms in Alzheimer's disease

Trifu SC, Ţîbîrnă A, Drăgoi AM, Cristea BM.

Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1033-1038. doi: 10.47162/RJME.61.4.05.

Circadian disturbances in Alzheimer's disease progression: a prospective observational cohort study of community-based older adults

Li P, Gao L, Gaba A, Yu L, Cui L, Fan W, Lim ASP, Bennett DA, Buchman AS, Hu K.

Lancet Healthy Longev. 2020 Dec;1(3):e96-e105. doi: 10.1016/s2666-7568(20)30015-5. Epub 2020 Nov 12.

Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease

Shi Y, Gu L, Wang Q, Gao L, Zhu J, Lu X, Zhou F, Zhu D, Zhang H, Xie C, Zhang Z.

J Gerontol A Biol Sci Med Sci. 2020 Mar 9;75(4):664-670. doi: 10.1093/gerona/glz005.

The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia

Hazen J, Vistnes M, Barca ML, Eldholm RS, Persson K, Brækhus A, Saltvedt I, Selbæk G, Engedal K, Knapskog AB.

Alzheimer Dis Assoc Disord. 2020 Jan-Mar;34(1):47-53. doi: 10.1097/WAD.0000000000000342.

Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease

Cantero JL, Atienza M, Lage C, Zaborszky L, Vilaplana E, Lopez-Garcia S, Pozueta A, Rodriguez-Rodriguez E, Blesa R, Alcolea D, Lleo A, Sanchez-Juan P, Fortea J; Alzheimer’s Disease Neuroimaging Initiative.

Cereb Cortex. 2020 Apr 14;30(4):2083-2098. doi: 10.1093/cercor/bhz224.

Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward

Alber J, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, DeBuc DC, Cordeiro F, Provetti-Cunha L, den Haan J, Van Stavern GP, Salloway SP, Sinoff S, Snyder PJ.

Alzheimers Dement. 2020 Jan;16(1):229-243. doi: 10.1002/alz.12006.

A meta-analysis on the levels of VILIP-1 in the CSF of Alzheimer's disease compared to normal controls and other neurodegenerative conditions

Mavroudis IA, Petridis F, Chatzikonstantinou S, Karantali E, Kazis D.

Aging Clin Exp Res. 2021 Feb;33(2):265-272. doi: 10.1007/s40520-019-01458-2. Epub 2020 Jan 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias